Scientists Develop $10 Chip That Could Enable Needle-Free Blood Glucose Monitoring in New Study

Could a tiny $10 sensor make needle-free blood glucose monitoring a reality? Researchers have developed a compact optical device capable of detecting important health biomarkers with high precision, potentially paving the way for affordable wearable technologies that monitor blood sugar without needles.

Developed by scientists at the University of Cambridge and GlitterinTech, the miniature sensor uses an innovative optical spectrometer design to analyse light and identify chemical substances. Measuring just a few centimetres, the device could eventually be integrated into wearable health monitors and portable diagnostic equipment.

Traditional spectrometers are widely used in medical testing, manufacturing and environmental monitoring. However, reducing their size typically compromises accuracy, resolution and measurement range.

The new technology, known as a convolutional spectrometer, uses mathematical principles to analyse light more efficiently, combining high precision with reduced computational requirements.

Built using a silicon nitride photonic platform, the sensor operates across near-infrared wavelengths ranging from 1,200 to 1,700 nanometres and can process measurements in less than a second.

During experimental testing, the device successfully identified substances including plastics, pharmaceuticals, coffee, flour and tea, achieving 100% classification accuracy in the reported tests.

It also measured chemical concentrations in different solutions with approximately 0.01% accuracy, demonstrating performance comparable to or better than commercial laboratory instruments under the tested conditions.

Importantly, researchers demonstrated its ability to measure several health indicators, including skin moisture, blood alcohol, lactate and glucose levels.

The team also conducted a preliminary demonstration of non-invasive glucose monitoring in one participant, suggesting potential applications in diabetes management.

Additionally, the sensor remained operational across temperatures ranging from -20°C to 80°C, highlighting its suitability for different environments.

However, researchers emphasised that further clinical validation is necessary before the technology can be used for routine blood glucose monitoring.

REFERENCE: Chunhui Yao, et al.; Optical convolutional spectrometer. Nature Photonics, 2026; 20 (6): 664 DOI: 10.1038/s41566-026-01891-6